[Diagnosis and therapy of multiple sclerosis].
The diagnosis of multiple sclerosis is still a clinical one, and depends on the occurrence of neurological symptoms due to lesions at two or more necessarily distinct sites in the white matter of the central nervous system. Up to now there exists no specific laboratory test for the diagnosis of multiple sclerosis. The cerebrospinal fluid-profile strongly supporting the diagnosis of multiple sclerosis consists of: cell count slightly elevated, total protein concentration normal or slightly elevated, in the electrophoresis distinct immunreaction without disturbance of the blood-brain-barrier, i.e. significant increase of gammaglobulins and IgG, oligoclonal pattern of the gammaglobulin subfractions. Newly developed diagnosistic possibilities are based on the determination of myelin basic protein, determination of the different glycerophosphatides and on the measurement of the activity of lipid hydrolyzing enzymes. Disturbances of lipid metabolism play an important role in the course of demyelination. Therapy of multiple sclerosis by steroids and immunsuppression will be discussed.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000175:diagnosis; D002528:Cerebellar Neoplasms / Q000175:diagnosis; D003937:Diagnosis, Differential; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000628:therapy; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D004676:Myelin Basic Protein / Q000134:cerebrospinal fluid; D005719:gamma-Globulins / Q000134:cerebrospinal fluid
D000305:Adrenal Cortex Hormones; D007074:Immunoglobulin G; D009125:Muscle Relaxants, Central; D004676:Myelin Basic Protein; D005719:gamma-Globulins; D006854:Hydrocortisone
Diagnostik und Therapie der Multiplen Sklerose.